Category: Licensing/Collaboration Deal Region: Asia · China Company: Everest Medicines Ltd

Everest Medicines Announces Partner Providence Reports Positive Top-Line Data from Phase 2 Primary Immunization Trial for mRNA COVID 19 Vaccine Candidate in Adults

By, Admin 1 min read
Share
Everest Medicines Announces Partner Providence Reports Positive Top-Line Data from Phase 2 Primary Immunization Trial for mRNA COVID 19 Vaccine Candidate in Adults
Levels of neutralizing antibodies generated by PTX-COVID19-B were non-inferior to Comirnaty

Found this useful? Share it with your team.

Welcome Back Sign in to Continue

Don't Have an Account? Sign Up!
Forgot Password?

Create your Account!

Don't Have an Account? Sign Up!